HomeNewsIndiaCentre says coronavirus’ Delta Plus variant, its lineages are of ‘concern’

Centre says coronavirus’ Delta Plus variant, its lineages are of ‘concern’

Around 40 cases of the Delta Plus variant of the novel coronavirus have now been detected in Maharashtra, Kerala and Madhya Pradesh, according to the Health Ministry.

June 23, 2021 / 15:05 IST
Story continues below Advertisement
People shop at a crowded roadside vegetable market after authorities eased coronavirus restrictions, following a drop in COVID-19 cases in Ahmedabad, India on June 15, 2021 (Image: Reuters/Amit Dave)
People shop at a crowded roadside vegetable market after authorities eased coronavirus restrictions, following a drop in COVID-19 cases in Ahmedabad, India on June 15, 2021 (Image: Reuters/Amit Dave)

The Centre reiterated on June 23 that the ‘Delta Plus’ variant of the novel coronavirus remains a “variant of concern”.

“The Delta variant as well as all Delta sub-lineages, including Delta Plus, are classified as VOC (variants of concern),” a statement posted by Union Health Minister Dr. Harsh Vardhan on Twitter read.

Story continues below Advertisement

The clarification came amid confusion over if the government had categorised it as a “variant of concern” or “variant of interest”.

During a press briefing on June 22, Union Health Secretary Rajesh Bhushan had said: “Any variant's transmissibility and virulence decide whether it is a variant of concern or interest. Delta variant is found in 80 countries around the world, including India and it is a variant of concern. Delta Plus variant has been detected in nine countries besides India. In India, 22 cases of Delta Plus variant have been found and it is in the category of variant of interest, (and) not yet in the category of variant of concern.”

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show